HealthEquity (FRA:2HE) Beta: -0.8730 (As of Jun. 25, 2026)


FRA:2HE HealthEquity Inc FRA:2HE
93 GF Score
Price €74.00
GF Value €87.87
! 1 Warning Sign
View Full Analysis

What is HealthEquity Beta?

HealthEquity FRA:2HE +2.07% 93 Beta is -0.8730 as of Jun. 25, 2026. GuruFocus rates FRA:2HE with a GF Score™ of 93/100 and a GF Value™ of €87.87. The stock has 1 warning sign investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), HealthEquity's Beta is -0.8730.


HealthEquity  (FRA:2HE) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


HealthEquity Beta Related Terms


HealthEquity Beta Historical Data

* Premium members only.

The historical data trend for HealthEquity's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthEquity Beta Chart

HealthEquity Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.06 0.65 -0.76 -0.48 -0.67

HealthEquity Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.61 -0.68 -0.77 -0.67 -0.90

FRA:2HE vs TEM, HNGE, DOCS: Beta Comparison

For the Health Information Services subindustry, HealthEquity's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Beta distribution charts can be found below:

* The bar in red indicates where HealthEquity's Beta falls into.


FRA:2HE
93GF Score
HealthEquity Inc FRA:2HE
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthEquity Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.8730 mean?
HealthEquity (FRA:2HE) has a Beta of -0.8730 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for HealthEquity and its competitors.
Is HealthEquity's Beta too high?
HealthEquity's current Beta is -0.8730. Overall, HealthEquity has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Beta compare to TEM and HNGE?
HealthEquity's Beta of -0.8730 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for HealthEquity and its competitors. HealthEquity's current Beta is -0.8730. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current Beta of -0.8730. The stock's GF Value™ is €87.87, compared to a current price of €74.00 — trading 15.8% below its estimated fair value. The current Beta is -0.8730. HealthEquity's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Beta is -0.8730 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthEquity (FRA:2HE) Overvalued in 2026?

Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued. The current stock price of €74.00 is trading 15.8% below its estimated GF Value™ of €87.87.

Key valuation signals for FRA:2HE:

  • Beta: -0.8730
  • GF Value™: €87.87 vs. price of €74.00 (15.8% below fair value)
  • GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthEquity Business Description

Other Exchanges HQY:USA
Address 15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
93GF Score

Get the complete analysis for FRA:2HE

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€74.00
Price
€87.87
GF Value